公开(公告)号：US20210236616A1

公开(公告)日：2021-08-05

申请号：US17234379

申请日：2021-04-19

申请人： EpicGenetics, Inc.

发明人： Bruce S. GILLIS

IPC分类号： A61K39/04 ,  A61P21/00

摘要： The invention provides methods and compositions for treating fibromyalgia (FM) and chronic fatigue syndrome (CFS) in an individual. The methods provided herein entail administering a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom. Also provided herein are methods for assessing alleviation of symptoms and/or alteration of immune system functioning following administration of a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom.

公开(公告)号：US20180348233A1

公开(公告)日：2018-12-06

申请号：US16002689

申请日：2018-06-07

申请人： EPICGENETICS, INC.

发明人： Bruce S. GILLIS

IPC分类号： G01N33/68

CPC分类号： G01N33/6863 ,  G01N33/6866 ,  G01N33/6869 ,  G01N2333/523 ,  G01N2333/5409 ,  G01N2333/5412 ,  G01N2333/5421 ,  G01N2333/5428 ,  G01N2333/57 ,  G01N2800/10 ,  G01N2800/2842 ,  G01N2800/50 ,  G01N2800/52 ,  G01N2800/60 ,  G01N2800/7095

摘要： The invention provides methods, kits and reagents for diagnosing fibromyalgia (FM) in an individual by determining whether the levels of one or more cytokines in the individual are altered, as compared to control levels. The altered level(s) or patterns of expression of the cytokines measured in the affected individual compared to the level from the control is predictive/indicative of FM in the individual.

公开(公告)号：US20190046628A1

公开(公告)日：2019-02-14

申请号：US16055565

申请日：2018-08-06

申请人： EpicGenetics, Inc.

发明人： Bruce S. GILLIS

IPC分类号： A61K39/04 ,  A61K9/00 ,  A61P21/00

摘要： The invention provides methods and compositions for treating fibromyalgia (FM) and chronic fatigue syndrome (CFS) in an individual. The methods provided herein entail administering a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom. Also provided herein are methods for assessing alleviation of symptoms and/or alteration of immune system functioning following administration of a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom.

公开(公告)号：US20200064356A1

公开(公告)日：2020-02-27

申请号：US16543741

申请日：2019-08-19

申请人： EpicGenetics, Inc.

发明人： Bruce S. GILLIS

IPC分类号： G01N33/68 ,  G01N33/547

摘要： The invention provides methods and compositions for treating attention-deficit/hyperactivity disorder (ADHD) in an individual. The methods provided herein entail administering a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom. Also provided herein are methods for assessing alleviation of symptoms and/or alteration of immune system functioning following administration of a composition comprising an isolated Mycobacterium or antigenic fragments derived therefrom.